Editorial: The radiological diagnosis of hepatocellular carcinoma

American Journal of Gastroenterology

Volumn 105, Issue 3, 2010, Pages 610-612

  Sherman, Morris ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; ULTRASOUND; VALIDATION STUDY; BIOPSY; DIFFERENTIAL DIAGNOSIS; LIVER TUMOR; NEOVASCULARIZATION (PATHOLOGY); NOTE; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIUM;

ALGORITHMS; BIOPSY; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PRACTICE GUIDELINES AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 77749277130     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.663     Document Type: Review

References (17)

1. Lee KH, O ' Malley ME, Haider MA, et al. Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol 2004;182:643-649
2. Lencioni R, Crocetti L, Della Pina MC, et al. Guidelines for imaging focal lesions in liver cirrhosis. Expert Rev Gastroenterol Hepatol 2008;2: 697-703.
3. Nakashima Y, Nakashima O, Hsia CC, et al. Vascularization of small hepatocellular carcinomas:correlation with differentiation. Liver 1999;19:12-18
4. Kojiro M. Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West. Hepatol Res 2007;37 (Suppl 2):S121-4.
5. Sala M, Llovet JM, Vilana R, et al., Barcelona Clínic Liver Cancer Group. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-1360
6. Nathan H, Schulick RD, Choti MA, et al. Predictors of survival aft er resection of early hepatocellular carcinoma. Ann Surg 2009;249:799-805.
7. Bruix J, Sherman M, Llovet JM, et al., EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430
8. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236
9. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis:prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008;47:97-104.
10. Khalili K, Kim TY, Jang HJ, et al. Implementation of AASLD hepatocellular carcinoma practice guidelines in North America:two years of experience. Hepatology 2008;48 (Suppl 1):362A.
11. Leoni S, Piscaglia F, Golfieri R, et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 2010;105:599-609.
12. Yu JS, Chung JJ, Kim JH, et al. Small hypervascular hepatocellular carcinomas: value of " washout " on gadolinium-enhanced dynamic MR imaging compared to superparamagnetic iron oxide-enhanced imaging. Eur Radiol 2009;19:2614-2622
13. Kim SH, Kim SH, Lee J, et al. Gadoxetic acid-enhanced MRI versus triplephase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009;192:1675-1681
14. Pathologic diagnosis of early hepatocellular carcinoma:a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009;49:658-664
15. Park YN, Kojiro M, Di TL, et al. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 2007;109:915-923
16. Libbrecht L, Severi T, Cassiman D, et al. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 2006;30: 1405-1411
17. Rimola J, Forner A, Reig M, et al. Cholangiocarcinoma in cirrhosis:absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009;50:791-798